Scott LiebmanPartner and Chair, FDA Regulatory & Compliance; Co-Chair, Life Sciences at Sheppard Mullin Richter & Hampton LLPSpeaker
Agenda Sessions
Policy Shifts Under the New Administration – Implications for Life Sciences
, 9:00amView Session